Responding to Emerging Enforcement Trends – Counterfeit Pills, Precursors, and Amphetamines

March 14, 2023 1:15pm

Ethan Davis
Partner
King & Spalding LLP

Jonathan Lenzner
Chief of Staff
Federal Bureau of Investigations

Uttam Dhillon
Partner | Chair, Regulatory Defense, Compliance & White Collar Practice Group
Michael Best & Friedrich LLP

Gabriel H. Scannapieco
Assistant Director, Consumer Protection Branch
United States Department of Justice

Moderator:

Gustav Eyler
Partner
Gibson, Dunn, & Crutcher LLP
Former Director of Consumer Protection Branch, U.S. Department of Justice

  • Update on expanded efforts to interdict counterfeit pills
  • Examining investigative and enforcement approaches aimed at stopping necessary precursor chemicals and equipment from reaching illegal drug manufacturers
  • Developing corporate engagement protocols to improve responsible sales, distribution, and reporting
  • Enforcement tools, approaches, and considerations related to amphetamine manufacturing, distribution, and dispensing
  • Compliance advice for corporate actors associated with or transacting in relevant chemicals, equipment, or drugs